Mahony James B
Regional Virology Laboratory, St Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.
Clin Microbiol Rev. 2008 Oct;21(4):716-47. doi: 10.1128/CMR.00037-07.
Clinical laboratories historically diagnose seven or eight respiratory virus infections using a combination of techniques including enzyme immunoassay, direct fluorescent antibody staining, cell culture, and nucleic acid amplification tests. With the discovery of six new respiratory viruses since 2000, laboratories are faced with the challenge of detecting up to 19 different viruses that cause acute respiratory disease of both the upper and lower respiratory tracts. The application of nucleic acid amplification technology, particularly multiplex PCR coupled with fluidic or fixed microarrays, provides an important new approach for the detection of multiple respiratory viruses in a single test. These multiplex amplification tests provide a sensitive and comprehensive approach for the diagnosis of respiratory tract infections in individual hospitalized patients and the identification of the etiological agent in outbreaks of respiratory tract infection in the community. This review describes the molecular methods used to detect respiratory viruses and discusses the contribution that molecular testing, especially multiplex PCR, has made to our ability to detect respiratory viruses and to increase our understanding of the roles of various viral agents in acute respiratory disease.
临床实验室历来通过酶免疫测定、直接荧光抗体染色、细胞培养和核酸扩增检测等多种技术组合来诊断七八种呼吸道病毒感染。自2000年以来发现了六种新型呼吸道病毒,实验室面临着检测多达19种可引起上、下呼吸道急性疾病的不同病毒的挑战。核酸扩增技术的应用,特别是与流体或固定微阵列相结合的多重PCR,为在单次检测中检测多种呼吸道病毒提供了一种重要的新方法。这些多重扩增检测为诊断个体住院患者的呼吸道感染以及识别社区呼吸道感染暴发中的病原体提供了一种灵敏且全面的方法。本综述描述了用于检测呼吸道病毒的分子方法,并讨论了分子检测,尤其是多重PCR,在我们检测呼吸道病毒的能力以及增进我们对各种病毒病原体在急性呼吸道疾病中作用的理解方面所做出的贡献。